Design, synthesis, antitumor estimation, and molecular docking of new imidazothiazolediones as potential dual EGFR and IDO1 inhibitors and apoptosis stimulators
Elsevier ·
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Design, synthesis, antitumor estimation, and molecular docking of new imidazothiazolediones as potential dual EGFR and IDO1 inhibitors and apoptosis stimulators. // Bioorganic & Medicinal Chemistry. – URL: https://www.sciencedirect.com/science/article/pii/S0968089626002440?dgcid=rss_sd_all
Design, synthesis, antitumor estimation, and molecular docking of new imidazothiazolediones as potential dual EGFR and IDO1 inhibitors and apoptosis stimulators. Bioorganic & Medicinal Chemistry. https://www.sciencedirect.com/science/article/pii/S0968089626002440?dgcid=rss_sd_all
“Design, synthesis, antitumor estimation, and molecular docking of new imidazothiazolediones as potential dual EGFR and IDO1 inhibitors and apoptosis stimulators.” Bioorganic & Medicinal Chemistry.
@article{article73546,
title = {Design, synthesis, antitumor estimation, and molecular docking of new imidazothiazolediones as potential dual EGFR and IDO1 inhibitors and apoptosis stimulators},
journal = {Bioorganic \& Medicinal Chemistry},
url = {https://www.sciencedirect.com/science/article/pii/S0968089626002440?dgcid=rss_sd_all}
}